Genesys (GNSY) 6-K Current report (foreign)

SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULES 13a-16 OR 15d-16 OFTHE SECURITIES EXCHANGE ACT OF 1934

For the Month of August 2005GENESYS S.A.(Exact name of registrant as specified in its charter)

L’Acropole, 954-980 avenue Jean Mermoz, 34000 Montpellier, FRANCE(Address of principal executive offices)

(Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.)

Form 20-F      X      Form 40-F         

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):____

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes           No      X    

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.

The following U.S. GAAP financial information is provided as a supplement to the Form 6-K submitted on August 10, 2005 under Accession Number 0000903423-05-000591.

US GAAP Annex

GENESYS S.A. 
U.S. GAAP CONSOLIDATED BALANCE SHEETS 
(Unaudited, in thousands of euros, except share data) 

		June 30, 2004		June 30, 2005
ASSETS		(in thousands of euros, except share data)
Current assets:
Cash and cash equivalents	€	12,269	€	8,486
Short-term portion of restricted cash		3,157		432
Un-billed accounts receivable		5,350		9,341
Accounts receivable, less allowances (€ 2,417 and € 2,097
at June. 30, 2004 and June 30,2005, respectively)		23,701		22,045
Prepaid expenses		2,201		2,314
Other current assets		5,294		4,622
Total current assets		51,972		47,240
Property and equipment, net		25,804		22,901
Goodwill, net		21,940		21,896
Customer lists, net		17,622		14,105
Technology, net		212		-
Investment in affiliated company		178		248
Deferred tax assets		235		463
Deferred financing costs, net		2,096		1,310
Other assets		1,875		1,663
Long-term portion of restricted cash		1,632		-
Total assets	€	123,566	€	109,826
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Bank overdrafts	€	2,904	€	3,322
Accounts payable		9,821		10,281
Accrued liabilities		5,343		4,832
Accrued compensation		7,320		6,778
Tax payable		8,426		6,229
Deferred revenue		108		57
Current portion of long-term debt		14,942		14,833
Current portion of capitalized lease obligations		15		37
Current portion of deferred tax liabilities		1,009		1,138
Current portion of other long-term liabilities		2,035		1,489
Other current liabilities		2,823		2,896
Total current liabilities		54,746		51,892
Long-term portion of long-term debt		80,710		66,244
Long-term portion of capitalized lease obligations		114		53
Long-term portion of deferred tax liabilities		4,016		2,748
Long-term portion of other long-term liabilities		1,828		749
Commitments and contingencies
Shareholders' equity:
Ordinary shares; €1.00 nominal value and 18,307,756 shares issued
and outstanding at June 30, 2004 and June 30, 2005		18,308		18,308
Common shares to be issued: €1.00 nominal value and 65,067 shares
at June 30, 2004 and June 30, 2005		65		65
Additional paid-in capital		197,130		197,129
Accumulated other comprehensive income		15,630		15,919
Deferred compensation				-
Accumulated deficit		(248,230)		(242,530)
		(17,097)		(11,109)
Less cost of treasury shares: 22,131 shares at June 30, 2004
and June 30, 2005		(751)		(751)
Total shareholders' equity		(17,848)		(11,860)
Total liabilities and shareholders' equity	€	123,566	€	109,826

GENESYS S.A.
U.S. GAAP CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands of euros, except share data)

	Three Months ended June 30,				Six Months ended June 30,
	2004		2005		2004		2005
	(in thousands, except share data)
Revenue :
Services	€	35,667	€	36,215	€	71,706	€	70,331
Products		24		31		202		37
		35,691		36,246		71,908		70,368
Cost of revenue :
Services		13,288		12,516		27,059		24,825
Products		15		6		43		36
		13,303		12,522		27,102		24,861
Gross profit		22,388		23,724		44,806		45,507
Operating expenses :
Research and development		963		663		2,083		1,295
Selling and marketing		10,021		10,329		18,987		19,595
General and administrative		8,542		8,758		18,186		16,253
Restructuring charge (credit)		1,076		(88)		2,090		238
Impairment of goodwill and other intangibles		75,401				75,401
Amortization of intangibles		1,734		877		3,483		1,823
Total operating expenses		97,737		20,539		120,230		39,205
Operating income (loss)		(75,349)		3,185		(75,424)		6,302
Financial income (expense)
Interest income		28		13		101		42
Interest expense		(1,367)		(1,387)		(2,571)		(2,462)
Foreign exchange gain (loss)		(216)		(81)		(1,845)		(606)
Other financial expense, net		(15)		(324)		(433)		(381)
Financial income (expense), net		(1,570)		(1,779)		(4,748)		(3,407)
Equity in income of affiliated company		5		33		37		36
Income (loss) before taxes		(76,914)		1,439		(80,135)		2,932
Income tax expense		6,676		(31)		6,520		244
Net income (loss)		(70,238)		1,408		(73,615)	€	3,175
Basic net income (loss) per share	€	(3.82)	€	0.08	€	(4.01)	€	0.17
Diluted net income (loss) per share	€	(3.82)	€	0.08	€	(4.01)	€	0.17
Number of shares used in computing basic
net income (loss) per share		18,372,841		18,372,841		18,372,841	18,372,841
Dilution effect on convertible notes
Number of shares used in computing diluted
net income (loss) per share		18,372,841		18,372,841		18,372,841		18,372,841

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: August 12, 2005

GENESYS SA
	By: /s/ François Legros                             Name: François Legros Title: Chairman and Chief Executive Officer